Home / Pancreatic Cancer
Following specialists treat Pancreatic Cancer.
Pancreatic cancer is a highly aggressive malignancy arising from a glandular organ, called pancreas. It is the fourth leading cause of cancer deaths in the United States. This is attributed to the late presentation and rapid metastasis of this cancer. There are various types of pancreatic cancers. The most common type is adenocarcinoma (an exocrine pancreatic cancer). It represents more than 80% of pancreatic cancers. Hence, this description will mainly cover the pancreatic adenocarcinoma. About 75% of pancreatic cancers involve the pancreatic head or neck. The remaining 15% to 25% occur in the body or tail of the pancreas.
Patients with pancreatic cancer may experience the following signs and symptoms:
The only definitive therapy is surgical resection. However, pancreatic cancer has a poor prognosis. Moreover, cancer may not be amenable to surgery in most instances. Chemotherapy and/or radiation therapy may be required.
Cancer of the pancreas is the 12th most common cancer in the U.S. but 4th leading cause of cancer related deaths in the US.Unfortunately, 80% of pancreatic cancer patients have terminal disease at the time of diagnosis with an average life expectancy of 4-6 months and has the lowest survival rate of all cancers. Pancreatic cancer mostly affects people between 55 and 84 years of age.
Feb 4, 2017
Cancer of the pancreas is one of the leading causes of cancer deaths in the Western world. The commonest and most aggressive form is adenocarcinoma of the pancreas, which accounts for 85% of cases. Typically late in producing characteristic signs and symptoms, it is all too often diagnosed when it has spread beyond the pancreas. Unfortunately, when it has reached this stage, it is considered to be incurable. The focus of treatment then shifts on to palliative care and possible life extension using radiotherapy and/or chemotherapy. Even with such therapy, the prognosis is still poor, with the median survival time after diagnosis being a miserable 3-6 months. The standard first-line chemotherapeutic agent is gemcitabine, given as single therapy. The problem with this drug is that, although it usually gives a good initial response, pancreatic cancer cells often become resistant to the drug and other, second line agents, often in combination, would then have to be used. One such agent is fluorouracil, given together with folinic acid (folinic acid is not a chemotherapeutic agent in itself but enhances the cancer-fighting actions of fluorouracil). Other drug combinations are also used as second-line agents, but all appear to offer more or less the same outcome.Read More
Cancer is the uncontrolled growth of cells which can arise from almost any tissue in the body. As well as growing in the place where they originate, many cancer cells also develop the ability to move around the body – or metastasise. Cancer can make people unwell in a huge number of ways; the growing mass can block structures (such as blood vessels or airways), the cancer tissue can consume the natural organ and prevent it from working, the metastases (new masses of cancer which grow around the body) can cause pain and blockages wherever they develop. In addition the growing tissue uses up a huge amount of energy, making the person feel very tired and lose huge amounts of weight as the cancer is ‘stealing’ all the person’s energy.Read More